Orencia Effective as Stand-alone Therapy in Children With polyarticular JIA, Phase 3 Trial Shows
News
Treatment with Orencia (abatacept) was effective and well-tolerated at four months in children and adolescents with polyarticular juvenile idiopathic arthritis (pJIA) who were intolerant or unresponsive to methotrexate, Phase 3 trials ... Read more